FromAstraZeneca ([email protected])
Subject (49)Enhertu recommended for breast cancer EU approval
Preheader (150)Enhertu recommended for approval in the EU by CHMP for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regim
Arial
Text Analysis
Body Words225
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px778 px
X-Spam Score0.6
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeAfternoon
